AU Patent

AU2002322466B2 — Linear and cyclic melanocortin receptor-specific peptides

Assigned to Palatin Technologies Inc · Expires 2007-08-30 · 19y expired

What this patent protects

Patent listed against bremelanotide-acetate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002322466B2
Jurisdiction
AU
Classification
—
Expires
2007-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Palatin Technologies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.